MarketBeat Instant News Alerts 2 hours agoAtlanta Braves' (BATRK) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "sell (d-)" rating on shares of Atlanta Braves in a report on Wednesday.NASDAQ:BATRKRead Atlanta Braves' (BATRK) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoAtkore's (ATKR) Hold (C-) Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings restated a "hold (c-)" rating on shares of Atkore in a research note on Wednesday.NYSE:ATKRRead Atkore's (ATKR) Hold (C-) Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Buy (B-) Rating for ATI (NYSE:ATI)MarketBeatWeiss Ratings reiterated a "buy (b-)" rating on shares of ATI in a research note on Wednesday.NYSE:ATIRead Weiss Ratings Reaffirms Buy (B-) Rating for ATI (NYSE:ATI)2 hours agoWeiss Ratings Reiterates "Sell (D-)" Rating for Atea Pharmaceuticals (NASDAQ:AVIR)MarketBeatWeiss Ratings restated a "sell (d-)" rating on shares of Atea Pharmaceuticals in a research note on Wednesday.NASDAQ:AVIRRead Weiss Ratings Reiterates "Sell (D-)" Rating for Atea Pharmaceuticals (NASDAQ:AVIR)2 hours agoAtara Biotherapeutics' (ATRA) "Sell (D+)" Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "sell (d+)" rating on shares of Atara Biotherapeutics in a report on Wednesday.NASDAQ:ATRARead Atara Biotherapeutics' (ATRA) "Sell (D+)" Rating Reaffirmed at Weiss Ratings2 hours agoAsure Software (NASDAQ:ASUR) Given Sell (D-) Rating at Weiss RatingsMarketBeatWeiss Ratings reiterated a "sell (d-)" rating on shares of Asure Software in a research note on Wednesday.NASDAQ:ASURRead Asure Software (NASDAQ:ASUR) Given Sell (D-) Rating at Weiss Ratings Trending News1D-Wave Quantum (NYSE:QBTS) Downgraded to "Strong Sell" Rating by Zacks Research2Quantum Computing Stocks To Keep An Eye On - October 7th3Zacks Research Issues Pessimistic Outlook for NIO Earnings4AST SpaceMobile, Inc. $ASTS Shares Sold by 111 Capital5Kraken Robotics (CVE:PNG) Sets New 12-Month High - What's Next?6IonQ (NYSE:IONQ) Shares Down 4.3% - Here's What Happened7MBL Wealth LLC Makes New $591,000 Investment in Solid Power, Inc. $SLDP8DraftKings (NASDAQ:DKNG) Shares Down 4.7% Following Analyst Downgrade All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoAstroNova (NASDAQ:ALOT) Given Sell (D) Rating at Weiss RatingsMarketBeatNASDAQ:ALOTRead AstroNova (NASDAQ:ALOT) Given Sell (D) Rating at Weiss Ratings2 hours agoAstronics (NASDAQ:ATRO) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:ATRORead Astronics (NASDAQ:ATRO) Earns Sell (D-) Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Astria Therapeutics (NASDAQ:ATXS)MarketBeatNASDAQ:ATXSRead Weiss Ratings Reaffirms Sell (D-) Rating for Astria Therapeutics (NASDAQ:ATXS)2 hours agoAstraZeneca (NASDAQ:AZN) Receives Buy (B) Rating from Weiss RatingsMarketBeatNASDAQ:AZNRead AstraZeneca (NASDAQ:AZN) Receives Buy (B) Rating from Weiss Ratings2 hours agoAstrana Health's (ASTH) "Hold (C-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ASTHRead Astrana Health's (ASTH) "Hold (C-)" Rating Reiterated at Weiss Ratings2 hours agoAstec Industries (NASDAQ:ASTE) Receives Hold (C) Rating from Weiss RatingsMarketBeatNASDAQ:ASTERead Astec Industries (NASDAQ:ASTE) Receives Hold (C) Rating from Weiss Ratings2 hours agoAssertio's (ASRT) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ASRTRead Assertio's (ASRT) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoAssembly Biosciences' (ASMB) Sell (D-) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ASMBRead Assembly Biosciences' (ASMB) Sell (D-) Rating Reiterated at Weiss Ratings2 hours agoASP Isotopes (NASDAQ:ASPI) Earns "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:ASPIRead ASP Isotopes (NASDAQ:ASPI) Earns "Sell (D-)" Rating from Weiss Ratings2 hours agoAscent Industries (NASDAQ:ACNT) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:ACNTRead Ascent Industries (NASDAQ:ACNT) Earns Sell (D-) Rating from Weiss Ratings2 hours agoAscendis Pharma A/S's (ASND) Sell (D-) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:ASNDRead Ascendis Pharma A/S's (ASND) Sell (D-) Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (E+) Rating for Arvinas (NASDAQ:ARVN)MarketBeatNASDAQ:ARVNRead Weiss Ratings Reiterates Sell (E+) Rating for Arvinas (NASDAQ:ARVN)2 hours agoArtiva Biotherapeutics (NASDAQ:ARTV) Receives Sell (E+) Rating from Weiss RatingsMarketBeatNASDAQ:ARTVRead Artiva Biotherapeutics (NASDAQ:ARTV) Receives Sell (E+) Rating from Weiss Ratings2 hours agoArtesian Resources' (ARTNA) Hold (C-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ARTNARead Artesian Resources' (ARTNA) Hold (C-) Rating Reaffirmed at Weiss Ratings2 hours agoArteris' (AIP) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:AIPRead Arteris' (AIP) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoARS Pharmaceuticals' (SPRY) "Sell (D-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:SPRYRead ARS Pharmaceuticals' (SPRY) "Sell (D-)" Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)MarketBeatNASDAQ:ARWRRead Weiss Ratings Reaffirms Sell (D-) Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)2 hours agoArrow Financial's (AROW) "Hold (C)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:AROWRead Arrow Financial's (AROW) "Hold (C)" Rating Reaffirmed at Weiss Ratings2 hours agoArriVent BioPharma (NASDAQ:AVBP) Given Sell (D-) Rating at Weiss RatingsMarketBeatNASDAQ:AVBPRead ArriVent BioPharma (NASDAQ:AVBP) Given Sell (D-) Rating at Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (E-)" Rating for Arrive AI (NASDAQ:ARAI)MarketBeatNASDAQ:ARAIRead Weiss Ratings Reaffirms "Sell (E-)" Rating for Arrive AI (NASDAQ:ARAI)2 hours agoArqit Quantum's (ARQQ) Sell (D) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:ARQQRead Arqit Quantum's (ARQQ) Sell (D) Rating Reaffirmed at Weiss Ratings2 hours agoPfizer Inc. (NYSE:PFE) Plans $0.43 Quarterly DividendMarketBeatNYSE:PFERead Pfizer Inc. (NYSE:PFE) Plans $0.43 Quarterly Dividend2 hours agoMP Materials (NYSE:MP) Shares Gap Up - Here's WhyMarketBeatNYSE:MPRead MP Materials (NYSE:MP) Shares Gap Up - Here's Why2 hours agoTeraWulf (NASDAQ:WULF) Shares Gap Up - Here's WhyMarketBeatNASDAQ:WULFRead TeraWulf (NASDAQ:WULF) Shares Gap Up - Here's Why Featured Articles and Offers3 Defense Stocks Surging as Ukraine Tensions DeepenBy Dan Schmidt | October 5, 2025Trump's Law S.1582: $21T Dollar Revolution ComingFrom Brownstone Research (Ad)General Dynamics Hits New Highs: Why It Might Keep ClimbingBy Jeffrey Neal Johnson | October 2, 2025D-Wave Quantum (NYSE:QBTS) Downgraded to "Strong Sell" Rating by Zacks ResearchBy MarketBeat | October 8, 2025Is BigBear.ai the Next Palantir? By Gabriel Osorio-Mazilli | October 3, 2025Man Who Called Nvidia at $1.10 Says Buy This Now...From The Oxford Club (Ad)Quantum Computing Stocks To Keep An Eye On - October 7thBy MarketBeat | October 9, 2025When Downgrades Create Opportunities: 3 Stocks to Watch NowBy Thomas Hughes | October 7, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
